STERIS /$STE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About STERIS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Ticker
$STE
Sector
Primary listing
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Employees
17,787
Website
STERIS Metrics
BasicAdvanced
$22B
36.05
$6.21
0.94
$2.28
1.02%
Price and volume
Market cap
$22B
Beta
0.94
52-week high
$252.79
52-week low
$200.98
Average daily volume
621K
Dividend rate
$2.28
Financial strength
Current ratio
1.957
Quick ratio
1.189
Long term debt to equity
30.886
Total debt to equity
33.292
Dividend payout ratio (TTM)
35.77%
Interest coverage (TTM)
11.37%
Profitability
EBITDA (TTM)
1,464.446
Gross margin (TTM)
44.31%
Net profit margin (TTM)
11.26%
Operating margin (TTM)
18.10%
Effective tax rate (TTM)
23.19%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
5.78%
Return on equity (TTM)
9.46%
Valuation
Price to earnings (TTM)
36.047
Price to revenue (TTM)
4.039
Price to book
3.33
Price to tangible book (TTM)
33.02
Price to free cash flow (TTM)
28.342
Free cash flow yield (TTM)
3.53%
Free cash flow per share (TTM)
789.24%
Dividend yield (TTM)
1.02%
Forward dividend yield
1.02%
Growth
Revenue change (TTM)
6.24%
Earnings per share change (TTM)
63.01%
3-year revenue growth (CAGR)
8.93%
10-year revenue growth (CAGR)
11.48%
3-year earnings per share growth (CAGR)
35.82%
10-year earnings per share growth (CAGR)
10.68%
3-year dividend per share growth (CAGR)
9.68%
10-year dividend per share growth (CAGR)
9.50%
What the Analysts think about STERIS
Analyst ratings (Buy, Hold, Sell) for STERIS stock.
Bulls say / Bears say
STERIS reported a 6% year-over-year increase in total revenue for Q3 2025, reaching $1.4 billion, surpassing analyst expectations. (gurufocus.com)
The Healthcare segment, STERIS's largest revenue contributor, grew by 7% to $976 million in Q3 2025, driven by a 9% increase in consumable revenue and 13% growth in service revenue. (gurufocus.com)
STERIS's Applied Sterilization Technologies (AST) segment experienced a 10% revenue increase to $258.1 million in Q3 2025, reflecting strong service revenue growth. (gurufocus.com)
STERIS's Life Sciences segment saw a 7% revenue decline to $136.4 million in Q3 2025, primarily due to divestitures and a decrease in capital equipment revenue. (gurufocus.com)
The company faces challenges from supply-chain constraints, higher material costs, and ongoing labor inflation, which have significantly impacted its margins. (nasdaq.com)
With nearly 30% of its revenues generated outside the United States, STERIS is exposed to foreign currency exchange rate fluctuations, which can significantly impact its financial position and competitive stance. (nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
STERIS Financial Performance
Revenues and expenses
STERIS Earnings Performance
Company profitability
STERIS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for STERIS stock?
STERIS (STE) has a market cap of $22B as of July 24, 2025.
What is the P/E ratio for STERIS stock?
The price to earnings (P/E) ratio for STERIS (STE) stock is 36.05 as of July 24, 2025.
Does STERIS stock pay dividends?
Yes, the STERIS (STE) stock pays dividends to shareholders. As of July 24, 2025, the dividend rate is $2.28 and the yield is 1.02%. STERIS has a payout ratio of 35.77% on a trailing twelve-month basis.
When is the next STERIS dividend payment date?
The next STERIS (STE) dividend payment date is unconfirmed.
What is the beta indicator for STERIS ?
STERIS (STE) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.